Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,971 | 3,983 | 4,006 | 3,657 | 4,051 |
| Operating Income | -3,971 | -3,983 | -4,006 | -3,657 | -4,051 |
| Other Income | 426 | 420 | 4,939 | -51 | 999 |
| Pre-tax Income | -3,545 | -3,563 | 933 | -3,707 | -3,052 |
| Net Income Continuous | -3,545 | -3,563 | 933 | -3,707 | -3,052 |
| Net Income | $-3,545 | $-3,563 | $933 | $-3,707 | $-3,052 |
| EPS Basic Total Ops | -0.04 | -0.04 | 0.02 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | 0.01 | -0.05 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.04 | 0.02 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | 0.01 | -0.05 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.05 | -0.05 | -0.04 |
| EBITDA(a) | $-3,954 | $-3,969 | $-3,992 | $-3,644 | $-4,043 |